Recommendations for surveillance and follow-up of men with testicular germ cell tumors: a multidisciplinary consensus conference by the Italian Germ cell cancer Group and the Associazione Italiana di Oncologia Medica.

Consensus Follow-Up Studies Humans Male Neoplasms, Germ Cell and Embryonal / diagnosis Practice Guidelines as Topic Seminoma / diagnosis Testicular Neoplasms / diagnosis

Consensus Follow-up Germ cell tumor Nonseminoma Recommendation Risk factor Seminoma Surveillance

Journal

Critical reviews in oncology/hematology

ISSN: 1879-0461

Titre abrégé: Crit Rev Oncol Hematol

Pays: Netherlands

ID NLM: 8916049

Informations de publication

Date de publication:
May 2019

Historique:

received: 09 01 2019

revised: 09 03 2019

accepted: 12 03 2019

entrez: 25 4 2019

pubmed: 25 4 2019

medline: 22 5 2019

Statut: ppublish

Résumé

No compelling evidence is available about surveillance and follow-up of patients with testicular germ cell tumour (TGCT). In the light of the best clinical evidence, the Italian Germ cell cancer Group (IGG) and the Associazione Italiana di Oncologia Medica (AIOM) set up a multidisciplinary national consensus conference, involving 42 leading experts and 3 TGCT survivors. A minimum of 50% of votes was required in order to achieve a consensus recommendation on 29 questions. Recommendations have been summarized in three tables, divided by stage I seminoma, stage I nonseminoma and the advanced disease, which may be useful for clinicians to appropriately choose the clinical investigation and its timing during the surveillance and follow-up of TGCT patients based on an accurate estimation of their risk of disease relapse. The IGG-AIOM consensus recommendations may help clinicians to choose appropriate clinical investigations for the surveillance and follow-up of TGCT patients.

Sections du résumé

BACKGROUND BACKGROUND

No compelling evidence is available about surveillance and follow-up of patients with testicular germ cell tumour (TGCT).

METHODS METHODS

In the light of the best clinical evidence, the Italian Germ cell cancer Group (IGG) and the Associazione Italiana di Oncologia Medica (AIOM) set up a multidisciplinary national consensus conference, involving 42 leading experts and 3 TGCT survivors. A minimum of 50% of votes was required in order to achieve a consensus recommendation on 29 questions.

RESULTS RESULTS

Recommendations have been summarized in three tables, divided by stage I seminoma, stage I nonseminoma and the advanced disease, which may be useful for clinicians to appropriately choose the clinical investigation and its timing during the surveillance and follow-up of TGCT patients based on an accurate estimation of their risk of disease relapse.

CONCLUSIONS CONCLUSIONS

The IGG-AIOM consensus recommendations may help clinicians to choose appropriate clinical investigations for the surveillance and follow-up of TGCT patients.

Identifiants

DOI: 10.1016/j.critrevonc.2019.03.006 PMID: 31014511

pubmed: 31014511

pii: S1040-8428(19)30058-7

doi: 10.1016/j.critrevonc.2019.03.006

pii:

doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

Pagination

154-164

Commentaires et corrections

Type : ErratumIn